Inhibition of tumor angiogenesis using a soluble receptor establishes a role for Tie2 in pathologic vascular growth

Journal of Clinical Investigation

Volumn 100, Issue 8, 1997, Pages 2072-2078

  Lin, Pengnian ^a   Polverini, Peter ^b   Dewhirst, Mark ^a   Shan, Siqing ^a   Rao, Prema S ^a   Peters, Kevin ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Angiogenesis; Cancer; Endothelium; Receptor tyrosine kinase; Tie2

Indexed keywords

CELL SURFACE RECEPTOR; PROTEIN TYROSINE KINASE; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL MODEL; ARTICLE; BREAST TUMOR; CELL PROLIFERATION; CONTROLLED STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PURIFICATION; RAT; TRANSGENIC MOUSE; TUMOR CELL CULTURE; TUMOR GROWTH; VASCULAR ENDOTHELIUM;

EID: 0030726988     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119740     Document Type: Article

References (39)

1. Folkman, J. 1990. What is the evidence that tumors are angiogenesis dependent? J. Natl. Cancer Inst. 82:4-6.
2. Folkman, J., and Y. Shing. 1992. Angiogenesis. J. Biol. Chem. 267:10931-10934.
3. Viglietto, G., D. Maglione, M. Rambaldi, J. Cerutti, A. Romano, F. Trapasso, M. Fedele, P. Ippolito, G. Chiapetta, G. Botti, et al. 1995. Upregulation of vascular endothelial growth factor (VEGF) and down regulation of placenta growth factor (PIGF) associated with malignancy in human thyroid tumors and cell lines. Oncogene. 11:1569-1579.
4. Kandel, J., E. Bossy-Wetzel, F. Radvanyi, M. Klagsbrun, J. Folkman, and D. Hanahan. 1991. Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma. Cell. 66:1095-1104.
5. Lyng, H., A. Skretting, and E.K. Rofstad. 1992. Blood flow in six human melanoma xenograft lines with different growth characteristics. Cancer Res. 52: 584-592.
6. Albo, D., M.S. Granick, N. Jhala, B. Atkinson, and M.P. Solomon. 1994. The relationship of angiogenesis to biological activity in human squamous cell carcinomas of the head and neck. Ann. Plast Surg. 32:588-594.
7. Bosari, S., A.K. Lee, R.A. DeLellis, B.D. Wiley, G.J. Heatley, and M.L. Silverman. 1992. Microvessel quantitation and prognosis in invasive breast carcinoma. Hum. Pathol. 23:755-761.
8. Denijn, M., and D.J. Ruiter. 1993. The possible role of angiogenesis in the metastatic potential of human melanoma. Clinicopathological aspects. Melanoma Res. 3:5-14.
9. Guinebretiere, J.M., G. Le Monique, and J. Bahi. 1994. Angiogenesis and risk of breast cancer in women with fibrocystic disease. J. Natl. Cancer Inst. 86: 635-636.
10. Macchiarini, P., M.J. Hardin, G. Fontanini, F. Squartini, and C.A. Angeletti. 1992. Relation of neovascularization to metastasis of non-small-cell lung cancer. Lancet. 340:145-146.
11. Toi, M., J. Kashitani, and T. Tominaga. 1993. Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma. Int. J. Cancer. 55:371-374.
12. Weidner, N., P.R. Carroll, J. Flax, W. Blumenfeld, and J. Folkman. 1993. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am. J. Pathology. 143:401-409.
13. Weidner, N., J. Folkman, F. Pozza, P. Bevilacqua, E.N. Allred, D.H. Moore, S. Meli, and G. Gasparini. 1992. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J. Natl. Cancer Inst. 84:1875-1887.
14. Weidner, N., J.P. Semple, W.R. Welch, and J. Folkman. 1991. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N. Engl. J. Med. 324:1-8.
15. Sunderkotter, C., K. Steinbrink, M. Goebeler, R. Bhardwaj, and C. Sorg. 1994. Macrophages and angiogenesis. J. Leukocyte Biol. 55:410-422.
16. Connolly, D.T. 1991. Vascular permeability factor: a unique regulator of blood vessel function. J. Cell Biochem. 47:219-223.
17. Ferrara, N., K.A. Houck, L.B. Jakeman, J. Winer, and D.W. Leung. 1991. The vascular endothelial growth factor family of polypeptides. J. Cell Biochem. 47:211-218.
18. Warren, R.S., H. Yuan, M.R. Matli, N.A. Gillett, and N. Ferrara. 1993. Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. J. Clin. Invest. 95: 1789-1797.
19. Plate, K.H., G. Breier, B. Millauer, A. Ullrich, and W. Risau. 1993. Upregulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis. Cancer Res. 53:5822-5827.
20. Plate, K.H., G. Breier, H.A. Weich, and W. Risau. 1992. Vascular endothelial growth factor is a potential tumor angiogenesis factor in human gliomas in vivo. Nature (Lond.). 359:845-848.
21. Hatva, E., A. Kaipainen, P. Mentula, J. Jaaskelainen, A. Paetau, M. Haltia, and K. Alitalo. 1995. Expression of endothelial cell-specific receptor tyrosine kinases and growth factors in human brain tumors. Am. J. Pathol. 146: 368-378.
22. Kim, K.J., B. Li, J. Winer, M. Armanini, N. Gillett, H.S. Phillips, and N. Ferrara. 1993. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature (Lond.). 362:841-844.
23. Millauer, B., M.P. Longhi, K.H. Plate, L.K. Shawver, W. Risau, A. Ullrich, and L.M. Strawn. 1996. Dominant-negative inhibition of Flk-1 suppresses the growth of many tumor types in vivo. Cancer Res. 56:1615-1620.
24. Millauer, B., L.K. Shawver, K.H. Plate, W. Risau, and A. Ullrich. 1994. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature (Lond.). 367:576-579.
25. Dumont, D.J., G.J. Gradwohl, G.-H. Fong, R. Auerbach, and M.L. Breitman. 1993. The endothelial-specific receptor tyrosine kinase, tek, is a member of a new subfamily of receptors. Oncogene. 8:1293-1301.
26. Iwama, A., I. Hamaguchi, M. Hashiyama, Y. Murayama, K. Yasungra, and T. Suda. 1993. Molecular cloning and characterization of mouse tie and tek receptor tyrosine kinase genes and their expression in hematopoietic cells. Biochem. Biophys. Res. Commun. 195:301-309.
27. Schnurch, H., and W. Risau. 1993. Expression of Tie2, a member of a novel family of receptor tyrosine kinase, in the endothelial cell lineage. Development. 119:957-968.
28. Dumont, D.J., G.H. Fong, M.C. Puri, G. Gradwohl, K. Alitalo, and M.L. Breitman. 1995. Vascularization of the mouse embryo: a study of flk-1, tek, tie, and vascular endothelial growth factor expression during development. Dev. Dyn. 203:80-92.
29. Sato, T.N., Y. Tozawa, U. Deutsch, K. Wolburg-Buchholz, Y. Fujiwara, M. Gendron-Maguire, T. Gridley, H. Wolburg, W. Risau, and Y. Qin. 1995. Distinct roles of the receptor tyrosine kinase Tie-1 and Tie2 in blood vessel formation. Nature (Lond.). 376:70-74.
30. Dumont, D.J., G. Gradwohl, G.H. Fong, M.C. Puri, M. Gertsenstein, A. Averbach, and M.L. Breitman. 1994. Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes and Dev. 8:1897-1909.
31. Suri, C. P.F. Jones, S. Patan, S. Bartunkova, P.C. Maisonpierre, S. Davis, T.N. Sato, and G.D. Yancopoulos. 1996. Requisite role of angiopoietin-1, a ligand for the Tie2 receptor, during embryonic angiogenesis. Cell. 87:1171-1180.
32. Davis, S., T.H. Aldrich, P.F. Jones, A. Acheson, D.L. Compton, V. Jain, T.E. Ryan, J. Bruno, C. Radziejewski, P.C. Maisonpierre, and G.D. Yancopoulos. 1996. Isolation of angiopoietin-1, a ligand for the tie2 receptor, by secretion-trap expression cloning. Cell. 87:1161-1169.
33. Papenfuss, D., J.F. Gross, M. Intaglitta, and F.A. Treese. 1979. A transparent access chamber for the rat dorsal skin fold. Microvasc. Res. 18:311-318.
34. Dewhirst, M.W., R.Z. Vinuya, E.T. Ong, B. Klitzman, G. Rosner, T.W. Secomb, and J.F. Gross. 1992. Effects of bradykinin on the hemodynamics of tumor and granulating normal tissue microvasculature. Radiat. Res. 130:345-354.
35. Polverini, P.J., N.P. Bouck, and F. Rastinejad. 1991. Assay for purification of naturally occurring inhibitors of angiogenesis. Methods Enzymol. 198: 440-450.
36. Dvorak, H.F., J.A. Nagy, J.T. Dvorak, and A.M. Dvorak. 1988. Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules. Am. J. Pathol. 133:95-109.
37. Blood, C.H., and B.R. Zetter. 1990. Tumor interactions with the vasculature: angiogenesis and tumor metastasis. Biochim. Biophys. Acta. 1032:89-118.
38. Vaupel, P., F. Kallinowski, and P. Okunieff. 1989. Blood flow, oxygen and nutrient supply, and metabolic microenviroment of human tumors: a review. Cancer Res. 49:6449-6465.
39. Jain, R.K. 1988. Determinants of tumor blood flow: a review. Cancer Res. 48:2641-2658.